Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

Cushman & Wakefield Echinox has been appointed to sell Joyson Safety Systems' industrial property in Ribiţa, Hunedoara County, as the automotive safety components manufacturer consolidates operations at its Arad hub.
Romanian authorities are making over €8 billion available this summer in EU funds and state aid for businesses and local public authorities, according to REI analysis, a consultancy group specialising in attracting non-reimbursable financing.
The National Road Investment Company (CNIR) has capitalised on European financial frameworks by signing the first two infrastructure contracts for the A8 Unirii (Union) Motorway.
Christian Tour, one of Romania's largest tour operators, has successfully completed its initial public offering (IPO), ahead of its listing on the BVB.
A Russian Geran-2 combat drone breached Romanian airspace and crashed into a residential apartment block in the eastern city of Galați early on 29 May, intensifying security concerns along NATO's eastern flank.